Fluent BioSciences

About:

Fluent Biosciences, a life science company, offering a molecular analysis of cells without the use of complex microfluidic instrumentation.

Website: https://www.fluentbio.com

Top Investors: Samsara BioCapital, Small Business Innovation Research, VC23, Civilization Ventures, Illumina Ventures

Description:

Fluent Biosciences is a life science "single cell" technology company that offers molecular analysis of cells without the use of complex microfluidic instrumentation. The company’s proprietary platform, Pre-Templated Instant Partitions (PIPseqTM), provides instantaneous self-assembly of individual cells or molecules into millions of uniform partitions for sensitive, unbiased preparation of proteins and nucleic acids for sequencing applications. Fluent's technology expands accessibility of single cell, molecule, or protein analysis to every laboratory, enabling broader market access across all researchers in biotech, pharma, and academic centers.

Total Funding Amount:

$22.9M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Watertown, Massachusetts, United States

Founded Date:

2018-02-20

Contact Email:

info(AT)fluentbio.com

Founders:

Adam Abate, Gary Zweiger, Sepehr Kiani, William (Bill) Hyun

Number of Employees:

11-50

Last Funding Date:

2024-03-21

IPO Status:

Private

Industries:

© 2025 bioDAO.ai